Guidelines on the Management of Atopic Dermatitis ... - Dermatology
Guidelines on the Management of Atopic Dermatitis ... - Dermatology
Guidelines on the Management of Atopic Dermatitis ... - Dermatology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
57. Booyle RJ, Bath-hextall FM, Le<strong>on</strong>ardi-Bee J et al. Probiotics for <strong>the</strong> treatment <strong>of</strong> dermatitis: a<br />
systematic review. Clin Exp Allergy 2009;39:1117-27<br />
58. Kramer MS. Breastfeeding and allergy: The evidence. Ann Nutr Metab 2011; 59(suppl 1):20-6<br />
59. Yang YW, Tsai CL, Lu CY. Exclusive breastfeeding and incident atopic dermatitis in childhood:<br />
a systematic review and meta-analysis <strong>of</strong> prospective cohort studies. Br J Dermatol<br />
2009;161:737-83<br />
60. Bath-Hextall FJ, Birnie AJ, Ravenscr<strong>of</strong>t JC, Williams HC. Interventi<strong>on</strong>s to reduce<br />
Staphylococcus aureus in <strong>the</strong> management <strong>of</strong> atopic dermatitis: an updated Cochrane review.<br />
Br J Dermatol 2010;163:12-26<br />
61. B<strong>on</strong>itas NG, Tatsi<strong>on</strong>i A, Bassioukas K, Ioannidis PA. Allergens resp<strong>on</strong>sible for allergic c<strong>on</strong>tact<br />
dermatitis am<strong>on</strong>gst children: a systematic review and meta-analysis. C<strong>on</strong>tact dermatitis<br />
2011;64:245-57<br />
62. Czarnobilska E, Obtulowicz K, Dyga W, Spiewak R. A half <strong>of</strong> schoolchildren with „ISAAC<br />
dermatitis‟ are ill with allergic c<strong>on</strong>tact dermatitis. J Eur Acad Dermatol Venereol 2011;25:1104-7<br />
63. Thomas KS, Dean T, O‟Leary C et al. A randomized c<strong>on</strong>trolled trial <strong>of</strong> i<strong>on</strong>-exchange water<br />
s<strong>of</strong>teners for <strong>the</strong> treatment <strong>of</strong> dermatitis in children. PLoS Med 2011; 8(2):<br />
e1000395.doi:10.1371/journal.pmed.1000395<br />
64. Vlachou C, Thomas KS, Williams HC. A case report and critical appraisal <strong>of</strong> <strong>the</strong> literature <strong>on</strong> <strong>the</strong><br />
use <strong>of</strong> DermaSilk in children with atopic dermatitis. Clin Exp Dermatol 2009; 34:e901-3<br />
65. Braham SJ, Pugashetti R, Koo J Maibach HI. Occlusive <strong>the</strong>rapy in atopic dermatitis: overview.<br />
J Dermatol Treat 2010;21:62-72<br />
66. Tarr A, Iheanacho I. Should we use bath emollients for atopic dermatitis? Br Med J<br />
2009;339:b4274<br />
67. Lee CH, Chuang HY, H<strong>on</strong>g CH et al. Lifetime exposure to cigarette smoking and <strong>the</strong><br />
development <strong>of</strong> adult-<strong>on</strong>set atopic dermatitis. Br J Dermatol 2011;164:483-9<br />
68. Masekela R, Moodley T, Mahlaba N et al. Atopy in HIV-infected children in Pretoria. S Afr Med<br />
J 2009;99:822-5<br />
69. Chida Y, Hamer M, Steptoe A. A bidirecti<strong>on</strong>al relati<strong>on</strong>ship between psychosocial factors and<br />
atopic disorders: a systematic review and meta-analysis. Psychosom Med 2008;70:102-16<br />
70. Yi O, Kw<strong>on</strong> HJ, Kim H et al. Effect <strong>of</strong> envir<strong>on</strong>mental tobacco smoke <strong>on</strong> atopic dermatitis am<strong>on</strong>g<br />
children in Korea. Envir<strong>on</strong> Res 2012;113:40-5<br />
71. Krämer U, Lemmen CH, Behrendt H,et al. The effect <strong>of</strong> envir<strong>on</strong>mental tobacco smoke <strong>on</strong><br />
eczema and allergic sensitizati<strong>on</strong> in children. Br J Dermatol 2004;150(1):111-8<br />
Epidemiology <strong>of</strong> atopic dermatitis<br />
How comm<strong>on</strong> is atopic dermatitis and who gets it?<br />
Much <strong>of</strong> <strong>the</strong> published work <strong>on</strong> <strong>the</strong> epidemiology <strong>of</strong> atopic dermatitis has been d<strong>on</strong>e <strong>on</strong><br />
children 1,2,3,4,5 and a variety <strong>of</strong> prevalence measures have been used, including lifetime<br />
prevalence, point prevalence and <strong>on</strong>e-year prevalence rates. The Internati<strong>on</strong>al Study <strong>of</strong><br />
Asthma and Allergies in Childhood ISAAC Phases I and III 6,7 have documented that <strong>the</strong> <strong>on</strong>eyear<br />
prevalence rate for atopic dermatitis symptoms varies worldwide dependent <strong>on</strong> <strong>the</strong><br />
populati<strong>on</strong> and geographic area studied (globally, nati<strong>on</strong>ally or locally). A comparis<strong>on</strong> <strong>of</strong> <strong>the</strong><br />
two studies documents a general decline or plateau <strong>on</strong>e-year prevalence rate in <strong>the</strong><br />
developed world, but an increasing prevalence in <strong>the</strong> developing world. 8<br />
There are few studies addressing <strong>the</strong> prevalence <strong>of</strong> atopic dermatitis in South African<br />
populati<strong>on</strong>s. The Phase I ISAAC study 6 <strong>of</strong> 13- to 14-year-old school children in Cape Town<br />
showed a 8.3% <strong>on</strong>e-year prevalence rate <strong>of</strong> atopic dermatitis symptoms, with 2,3% having<br />
severe disease (sleep disturbance for >1 night per week). The Phase III follow-up study 7